OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
Morna J. Dorsey, Arye Rubinstein, Heather K. Lehman, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 5, pp. 951-964
Open Access | Times Cited: 12
Morna J. Dorsey, Arye Rubinstein, Heather K. Lehman, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 5, pp. 951-964
Open Access | Times Cited: 12
Showing 12 citing articles:
Beyond In Vivo, Pharmaceutical Molecule Production in Cell-Free Systems and the Use of Noncanonical Amino Acids Therein
Marco G. Casteleijn, Ulrike Abendroth, Anne Zemella, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
Marco G. Casteleijn, Ulrike Abendroth, Anne Zemella, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
Approved delivery strategies for biopharmaceuticals
Makhloufi Zoulikha, Zhongjian Chen, Jun Wu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 110225-110225
Closed Access | Times Cited: 7
Makhloufi Zoulikha, Zhongjian Chen, Jun Wu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 110225-110225
Closed Access | Times Cited: 7
Escherichia coli in the production of biopharmaceuticals
İbrahim İncir, Özlem Kaplan
Biotechnology and Applied Biochemistry (2024)
Open Access | Times Cited: 4
İbrahim İncir, Özlem Kaplan
Biotechnology and Applied Biochemistry (2024)
Open Access | Times Cited: 4
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy
Morna J. Dorsey, Manish J. Butte, Jay R. Lieberman, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Open Access
Morna J. Dorsey, Manish J. Butte, Jay R. Lieberman, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Open Access
Tired of the confusion around pleural effusions: Adenosine deaminase detection sets the record straight!
Kai‐Yan Liu, Xiaobing Li
World Journal of Clinical Cases (2025) Vol. 13, Iss. 21
Closed Access
Kai‐Yan Liu, Xiaobing Li
World Journal of Clinical Cases (2025) Vol. 13, Iss. 21
Closed Access
Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency
Elizabeth Daly Hicks, Geoffrey Hall, Michael S. Hershfield, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 5
Open Access | Times Cited: 2
Elizabeth Daly Hicks, Geoffrey Hall, Michael S. Hershfield, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 5
Open Access | Times Cited: 2
Advances in conjugate drug delivery System: Opportunities and challenges
Yishen Zhu, Jiaqi Wu, Feng Zhi
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124867-124867
Closed Access | Times Cited: 2
Yishen Zhu, Jiaqi Wu, Feng Zhi
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124867-124867
Closed Access | Times Cited: 2
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study
Masafumi Onodera, Toru Uchiyama, Tadashi Ariga, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 4
Masafumi Onodera, Toru Uchiyama, Tadashi Ariga, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 4
Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design
Takuo Ogihara, Kenta Mizoi, Akiko Ishii‐Watabe
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1456-1456
Open Access | Times Cited: 3
Takuo Ogihara, Kenta Mizoi, Akiko Ishii‐Watabe
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1456-1456
Open Access | Times Cited: 3
Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023
Ian T. T. Liu, Aaron S. Kesselheim
The Journal of Pediatrics (2024) Vol. 275, pp. 114211-114211
Closed Access
Ian T. T. Liu, Aaron S. Kesselheim
The Journal of Pediatrics (2024) Vol. 275, pp. 114211-114211
Closed Access
Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant
Maria Rain Jennings, S.J. Min, Grace S. Xu, et al.
Protein Expression and Purification (2023) Vol. 213, pp. 106362-106362
Open Access | Times Cited: 1
Maria Rain Jennings, S.J. Min, Grace S. Xu, et al.
Protein Expression and Purification (2023) Vol. 213, pp. 106362-106362
Open Access | Times Cited: 1
The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine
Michele A. Kutzler, Gina Cusimano, David Joyner, et al.
Research Square (Research Square) (2024)
Open Access
Michele A. Kutzler, Gina Cusimano, David Joyner, et al.
Research Square (Research Square) (2024)
Open Access
